Is AVTXF or JNJ a better dividend investment in 2026?

AVTXF currently yields 26.14% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: AVTXF offers higher current income.

What is the dividend yield difference between AVTXF and JNJ?

AVTXF has a forward dividend yield of 26.14% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 22.78 percentage points.

Home › Compare › AVTXF vs JNJ

AVTXF vs JNJ: Dividend Comparison 2026

AVTXF yields 26.14% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 AVTXF wins by $85.7K in total portfolio value

INVESTMENT

TIME HORIZON10 years

AVTXF

● Live price

26.14%

Share price

$7.65

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$105.7K

Annual income

$12,398.23

Full AVTXF calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — AVTXF vs JNJ

📍 AVTXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	AVTXF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, AVTXF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

AVTXF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AVTXF

Annual income on $10K today (after 15% tax)

$2,222.22/yr

After 10yr DRIP, annual income (after tax)

$10,538.50/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, AVTXF beats the other by $9,834.88/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AVTXF + JNJ for your $10,000?

AVTXF: 50%JNJ: 50%

100% JNJ50/50100% AVTXF

Portfolio after 10yr

$62.9K

Annual income

$6,613.01/yr

Blended yield

10.52%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

AVTXF

No analyst data

Altman Z

-2.3

Piotroski

2/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AVTXF buys

JNJ buys

No recent congressional trades found for AVTXF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricAVTXFJNJ

Forward yield	26.14% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$105.7K ✓	$20.0K
Annual income after 10y	$12,398.23 ✓	$827.78
Total dividends collected	$68.2K ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: AVTXF vs JNJ ($10,000, DRIP)

Year	AVTXF Portfolio	AVTXF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$13,314	$2,614.38	$10,676	$355.77	+$2.6K → AVTXF
2	$17,500	$3,253.16	$11,407	$389.39	+$6.1K → AVTXF
3	$22,721	$3,996.02	$12,198	$426.53	+$10.5K → AVTXF
4	$29,160	$4,848.82	$13,056	$467.62	+$16.1K → AVTXF
5	$37,017	$5,815.91	$13,987	$513.12	+$23.0K → AVTXF
6	$46,508	$6,900.01	$14,998	$563.56	+$31.5K → AVTXF
7	$57,866	$8,102.04	$16,098	$619.52	+$41.8K → AVTXF
8	$71,337	$9,421.13	$17,295	$681.69	+$54.0K → AVTXF
9	$87,186	$10,854.65	$18,599	$750.82	+$68.6K → AVTXF
10	$105,687	$12,398.23	$20,022	$827.78	+$85.7K → AVTXF

AVTXF vs JNJ: Complete Analysis 2026

AVTXF — Stock

Avantium N.V., a chemical technology company, develops and commercializes renewable chemistry solutions in the Netherlands. The company operates through three segments: Avantium Catalysis, Avantium Renewable Chemistries, and Avantium Renewable Polymers. It offers furandicarboxylic acid, a building block for polyethylene furanoate (PEF); and PEF, a plant-based recyclable plastic for use as packaging material. The company also provides catalyst testing systems, including Flowrence that provides catalyst testing and adsorbents. In addition, the company R&D system, services, and refinery catalyst testing services. Further, it develops ray technology to produce mono-ethylene glycol from industrial sugars; and dawn technology which converts non-food plant-based feedstock to industrial sugars and lignin. Additionally, the company produces polyesters using plantMEG. Avantium N.V. was founded in 2000 and is headquartered in Amsterdam, the Netherlands.

Full AVTXF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this AVTXF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AVTXF vs SCHD AVTXF vs JEPI AVTXF vs O AVTXF vs KO AVTXF vs MAIN AVTXF vs ABBV AVTXF vs MRK AVTXF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.